Staphylococcus aureus community-onset pneumonia in patients admitted to children's hospitals during autumn and winter of 2006-2007

Epidemiology and Infection

Volumn 138, Issue 5, 2010, Pages 666-672

  Kallen, A J ^a,b   Reed, C ^b,c   Patton, M ^b,c   Arnold, K E ^d   Finelli, L ^c   Hageman, J ^a  

^a NATIONAL CENTER FOR PREPAREDNESS DETECTION AND CONTROL OF INFECTIOUS DISEASES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^d GEORGIA DEPARTMENT OF HUMAN RESOURCES   (United States)

Author keywords

Antimicrobial resistance; Paediatric pneumonia; S. aureus

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; AZITHROMYCIN; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; IMMUNOSUPPRESSIVE AGENT; LINEZOLID; NONSTEROID ANTIINFLAMMATORY AGENT; RIFAMPICIN; STEROID; TETRACYCLINE; VANCOMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; AUTUMN; CHILD; CHILDHOOD DISEASE; COMMUNITY ONSET PNEUMONIA; COUGHING; DYSPNEA; FEVER; HEALTH CARE PERSONNEL; HOSPITAL ADMISSION; HUMAN; INFECTIOUS PNEUMONIA; LETHARGY; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; PEDIATRIC HOSPITAL; PRESCHOOL CHILD; RHINORRHEA; STAPHYLOCOCCAL PNEUMONIA; SYMPTOM; TACHYPNEA; VOMITING; WHEEZING; WINTER; COMMUNICABLE DISEASE; DRUG EFFECT; FEMALE; HOSPITALIZATION; INFANT; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MORTALITY; PENICILLIN RESISTANCE; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HOSPITALIZATION; HUMANS; INFANT; MALE; METHICILLIN RESISTANCE; PNEUMONIA, STAPHYLOCOCCAL; RESPIRATION, ARTIFICIAL; STAPHYLOCOCCUS AUREUS;

EID: 77950896564     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S095026880999135X     Document Type: Article

References (21)

1. Ruiz M, et al. Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity. American Journal of Respiratory and Critical Care Medicine 1999; 160: 397-405.
2. Stankovic C, Mahajan P, Asmar BI. Methicillinresistant Staphylococcus aureus as a cause of community- acquired pneumonia. Current Infectious Disease Reports 2007; 9: 223-227.
3. Chickering HT, Park JH. Staphylococcus aureus pneumonia. New England Journal of Medicine 1919; 72: 617-626.
4. Robertson L, Caley JP, Moore J. Importance of Staphylococcus aureus in pneumonia in the 1957 epidemic of influenza A. Lancet 1958; 2: 233-236.
5. Martin CM, et al. Asian influenza A in Boston, 1957-1958. Archives of Internal Medicine 1959; 103: 532-542.
6. Bhat N, et al. Influenza-associated deaths among children in the United States, 2003-2004. New England Journal of Medicine 2005; 353: 2559-2567.
7. Finelli L, et al. Influenza-associated pediatric mortality in the United States : increase of Staphylococcus aureus coinfection. Pediatrics 2008; 122: 805-811.
8. Kallen AJ, et al. Characteristics of Staphylococcus aureus community-acquired pneumonia during the 2006-2007 influenza season. Clinical Infectious Diseases 2007; 45: 1655.
9. Centers for Disease Control and Prevention. Severe methicillin-resistant Staphylococcus aureus communityacquired pneumonia associated with influenza - Louisiana and Georgia, December 2006-January2007. Morbidity and Mortality Weekly Report 2008; 25: 325-329.
10. Hageman JC, et al. Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-2004 influenza season. Emerging Infectious Diseases 2006; 12: 894-899.
11. Gillet Y, et al. Factors predicting mortality in necrotizing community-acquired pneumonia caused by Staphylococcus aureus containing Panton-Valentine leukocidin. Clinical Infectious Diseases 2007; 45: 315-321.
12. Kallen AJ, et al. Staphylococcus aureus communityacquired pneumonia during the 2006-2007 influenza season. Annals of Emergency Medicine 2008; 53: 358-365.
13. Mandell LA, et al. Infectious Diseases Society of America/American Thoracic Society consensus guide lines on the management of community-acquired pneumonia in adults. Clinical Infectious Diseases 2007; 44: S27-S72.
14. American Thoracic Society. Guidelines for the management of adults with hospital-acquired, ventilatorassociated, and healthcare-associated pneumonia. American Journal of Respiratory and Critical Care Medicine 2005; 171: 388-416.
15. Louria DB, et al. Studies on influenza in the pandemic of 1957-1958. II. Pulmonary complications of influenza. Journal of Clinical Investigation 1959; 38: 213-265.
16. Schwarzmann SW, et al. Bacterial pneumonia during the Hong Kong influenza epidemic of 1968-1969. Archives of Internal Medicine 1971; 127: 1037-1041.
17. Fisher AM, et al. Staphylococcal pneumonia: a review of 21 cases in adults. New England Journal of Medicine 1958; 258: 919-928.
18. Francis JS, et al. Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentin leukocidin genes. Clinical Infectious Diseases 2005; 40: 100-107.
19. Centers for Disease Control and Prevention. Four pediatric deaths from community-acquired methicillinresistant Staphylococcus aureus - Minnesota and North Dakota, 1997-1999. Morbidity and Mortality Weekly Report 1999; 48: 707-710.
20. Fridkin SK, et al. Methicillin-resistant Staphylococcus aureus disease in three communities. New England Journal of Medicine 2005; 352: 1436-1444.
21. Moran GJ, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. New England Journal of Medicine 2006; 355: 666-674.